Abstract
Metastatic liver disease is one of the major causes of cancer-related morbidity and
mortality. Locoregional therapies offered by interventional oncologists alleviate
cancer-related morbidity and in some cases improve survival. Locoregional therapies
are often palliative in nature but occasionally can be used with curative intent.
This review will discuss important factors to consider prior to palliative and curative
intent treatment of metastatic liver disease with locoregional therapy. These factors
include those specific to the tumor, liver function, liver reserve, differences between
treatment modalities, and patient-specific considerations.
Keywords
hepatic metastases - locoregional therapy - transarterial therapy - ablation - liver
reserve
